Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2020

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Pricing of $10M Public Offering

Posted on December 23, 2020 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced the pricing of an underwritten public offering of 5,000,000 shares of common … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Aims to Identify Best Delivery Method for Lead Drug Candidate

Posted on December 22, 2020 by MissionIR

AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, recently submitted a protocol amendment request to the U.S. Food and Drug Administration (“FDA”). Approval of the amendment will allow AzurRx … Continue reading →

Posted in AzurRx BioPharma Inc. AZRX | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Poised in Convergence of Digital Technologies, Engagement

Posted on December 22, 2020 by MissionIR

SRAX (NASDAQ: SRAX), focused on unlocking data and insights through its software-as-a-service (“Saas”) platform, Sequire, is emerging as a leader within the investor intelligence field. Launched as a stand-alone platform in early 2020, Sequire has amassed over 1 million investors … Continue reading →

Posted in Small Cap News, SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Reaches Another Significant Milestone with Scaled-up Production of Clinical-Grade REQORSA(TM)

Posted on December 22, 2020 by MissionIR

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, has announced its completion of the manufacturing scale-up of REQORSA(TM) immunogene therapy. Subject to satisfactory completion of final testing currently underway, the clinical-grade production is intended … Continue reading →

Posted in Genprex Inc. GNPX | Leave a comment

MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Applauds Bipartisan Appropriation of Funds for US Uranium Reserve

Posted on December 22, 2020 by MissionIR

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the largest uranium miner in the U.S., applauds the bipartisan, bicameral launch of the U.S. uranium reserve, as $75 million of funding was included in the omnibus appropriation bill. The bill, passed last … Continue reading →

Posted in Energy Fuels Inc. UUUU, MissionIRNewsBreaks | Leave a comment

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moving Forward with Clinical Trials in 2021 after Receiving FDA Approval for IND for Berubicin

Posted on December 22, 2020 by MissionIR

The company is scheduled to conduct three clinical trials in 2021 for Berubicin – two Phase II and the first-ever Phase I in pediatric patients FDA modified the trial design to designate overall survival as the trial’s primary endpoint The … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Net Element (NASDAQ: NETE) Gets Its Timing Spot-on as Electric Vehicle Industry Logs Record Month

Posted on December 22, 2020 by MissionIR

By September 2020, growth rate of electric vehicle market increased to over 11% YoY September 2020 marked record month for the EV industry, as 345,000 electric vehicles were sold globally – accounting for 4.9% of total automotive sales Increase in … Continue reading →

Posted in Net Element Inc. NETE | Leave a comment

MissionIRNewsBreaks – Knightscope Inc. Announces Launch of Its Public Safety App

Posted on December 22, 2020 by MissionIR

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced the availability of a new app designed to involve the community to assist in reimagining public safety. According to the update, the Knightscope Public … Continue reading →

Posted in Knightscope, Inc., MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Knightscope Inc. Expands ASR Solution to Include Optional Elevated Body Temperature (‘EBT’) Detection

Posted on December 21, 2020 by MissionIR

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that, in an effort assist in combating the spread of COVID-19, it has developed a way for its clients to measure body temperatures of … Continue reading →

Posted in Knightscope, Inc. | Leave a comment

Knightscope’s AI-enhanced Security Robots Herald a New Age in Property Protection

Posted on December 21, 2020 by MissionIR

Market analysts foresee a revenue-building trend in the global autonomous robotic security during the coming decade, and autonomous robot developer Knightscope is in a competitive position to take advantage of the trend Many AI-enhanced robot sentries are already making appearances … Continue reading →

Posted in Knightscope, Inc., Small Cap News | Leave a comment